Lipid Management in Chronic Kidney Disease, Hemodialysis, and Transplantation

Terri Montague; Barbara Murphy

doi:10.1016/j.ecl.2008.11.004

Lipid Management in Chronic Kidney Disease, Hemodialysis, and Transplantation

Terri Montague, Barbara Murphy

Research output: Contribution to journal › Review article › peer-review

13 Scopus citations

Abstract

Recent studies have shown the spectrum of dyslipidemia in patients who have chronic kidney disease (CKD) or end-stage renal disease to be different from that of the general population. This article discusses the pathophysiology of dyslipidemia in CKD, dialysis, and renal transplant patients, the therapeutic options, and their association with clinical outcomes. Whenever possible, comparisons are made to outcomes in the general population.

Original language	English
Pages (from-to)	223-234
Number of pages	12
Journal	Endocrinology and Metabolism Clinics of North America
Volume	38
Issue number	1
DOIs	https://doi.org/10.1016/j.ecl.2008.11.004
State	Published - Mar 2009

Keywords

Chronic kidney disease
Hemodialysis
Hyperlipidemia
Renal transplantation
Statin

Access to Document

10.1016/j.ecl.2008.11.004

Cite this

@article{fac407399b5b46b089364fe3c5bba846,

title = "Lipid Management in Chronic Kidney Disease, Hemodialysis, and Transplantation",

abstract = "Recent studies have shown the spectrum of dyslipidemia in patients who have chronic kidney disease (CKD) or end-stage renal disease to be different from that of the general population. This article discusses the pathophysiology of dyslipidemia in CKD, dialysis, and renal transplant patients, the therapeutic options, and their association with clinical outcomes. Whenever possible, comparisons are made to outcomes in the general population.",

keywords = "Chronic kidney disease, Hemodialysis, Hyperlipidemia, Renal transplantation, Statin",

author = "Terri Montague and Barbara Murphy",

year = "2009",

month = mar,

doi = "10.1016/j.ecl.2008.11.004",

language = "English",

volume = "38",

pages = "223--234",

journal = "Endocrinology and Metabolism Clinics of North America",

issn = "0889-8529",

publisher = "W.B. Saunders",

number = "1",

}

TY - JOUR

T1 - Lipid Management in Chronic Kidney Disease, Hemodialysis, and Transplantation

AU - Montague, Terri

AU - Murphy, Barbara

PY - 2009/3

Y1 - 2009/3

N2 - Recent studies have shown the spectrum of dyslipidemia in patients who have chronic kidney disease (CKD) or end-stage renal disease to be different from that of the general population. This article discusses the pathophysiology of dyslipidemia in CKD, dialysis, and renal transplant patients, the therapeutic options, and their association with clinical outcomes. Whenever possible, comparisons are made to outcomes in the general population.

AB - Recent studies have shown the spectrum of dyslipidemia in patients who have chronic kidney disease (CKD) or end-stage renal disease to be different from that of the general population. This article discusses the pathophysiology of dyslipidemia in CKD, dialysis, and renal transplant patients, the therapeutic options, and their association with clinical outcomes. Whenever possible, comparisons are made to outcomes in the general population.

KW - Chronic kidney disease

KW - Hemodialysis

KW - Hyperlipidemia

KW - Renal transplantation

KW - Statin

UR - http://www.scopus.com/inward/record.url?scp=59649099215&partnerID=8YFLogxK

U2 - 10.1016/j.ecl.2008.11.004

DO - 10.1016/j.ecl.2008.11.004

M3 - Review article

C2 - 19217521

AN - SCOPUS:59649099215

SN - 0889-8529

VL - 38

SP - 223

EP - 234

JO - Endocrinology and Metabolism Clinics of North America

JF - Endocrinology and Metabolism Clinics of North America

IS - 1

ER -

Lipid Management in Chronic Kidney Disease, Hemodialysis, and Transplantation

Abstract

Keywords

Access to Document

Fingerprint

Cite this